Related Experiment Videos
[Detection and management of lipid disorders in the diabetic patient]
C Laudo Pardos1, V Puigddevall Gallego, L San Martín Barrio
1Dpto. de Farmacología, Colegio Universitario de Soria.
Insights
Diabetic patients face higher risks of macrovascular diseases like heart attack and stroke. Stricter lipid-lowering goals are crucial, especially for women, with lifestyle changes and medication as key interventions.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Context:
- Diabetes mellitus significantly elevates the risk of macrovascular complications, including ischemic heart disease, stroke, and peripheral vascular disease.
- Diabetic patients exhibit accelerated atherogenesis, increasing their susceptibility to cardiovascular events.
- Women with diabetes require particular attention due to potentially higher risks associated with macrovascular disease.
Purpose:
- To emphasize the need for more stringent therapeutic lipid-lowering goals in diabetic individuals.
- To outline a stepwise approach to managing dyslipidemia in diabetes.
- To highlight the importance of comprehensive metabolic control.
Summary:
- The primary therapeutic strategy involves achieving optimal metabolic control through diet, exercise, and pharmacotherapy (insulin or oral antidiabetics).
- If lifestyle modifications and basic antidiabetic treatments are insufficient, the addition of hypolipidemic drugs is recommended.
- Aggressive lipid management is essential to mitigate the increased risk of macrovascular disease in the diabetic population.
Impact:
- Implementing stricter lipid targets can reduce the incidence of major adverse cardiovascular events in diabetic patients.
- Improved metabolic and lipid control contributes to a better long-term prognosis and reduced morbidity and mortality.
- This approach supports personalized treatment strategies, particularly for high-risk groups like diabetic women.
Abstract:
Diabetics patients have a greater risk of morbi-mortality associated to macrovascular disease, which may show as ischemic cardiopathy, stroke and peripheric vascular disease. The high atherogenesis in these patients. Consequently, the therapeutical goals aimed to the reduction of plasmatic lipids must be stricter among the diabetic population and, especially, among women, that among non-diabetic subjects. The first therapeutical step should be to reach a proper metabolic control through diet, exercise and, if necessary, insulin or oral antidiabetics. If these measures are not enough, hypolipemic drugs should be added.